Medical Course and Complications After Lung Transplantation

  • Guillermo Garrido
  • Gundeep S. Dhillon


Lung transplant prolongs life and improves quality of life in patients with end-stage lung disease. However, survival of lung transplant recipients is shorter compared to patients with other solid organ transplants, due to many unique features of the lung allograft. Patients can develop a multitude of noninfectious (e.g., primary graft dysfunction, pulmonary embolism, rejection, acute and chronic, renal insufficiency, malignancies) and infectious (i.e., bacterial, fungal, and viral) complications and require complex multidisciplinary care. This chapter discusses medical course and complications that patients might experience after lung transplantation.


Lung transplantation Rejection Bronchiolitis obliterans syndrome Outcomes Complications 


  1. 1.
    Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, et al. The registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report--2013; focus theme: age. J Heart Lung Transplant. 2013;32(10):965–78.PubMedCrossRefGoogle Scholar
  2. 2.
    Gross CR, Savik K, Bolman RM 3rd, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest. 1995;108(6):1587–93.PubMedCrossRefGoogle Scholar
  3. 3.
    Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation Report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1037–46.PubMedCrossRefGoogle Scholar
  4. 4.
    Contreras AG, Briscoe DM. Every allograft needs a silver lining. J Clin Invest. 2007;117(12):3645–8.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Dhillon GS, Zamora MR, Roos JE, Sheahan D, Sista RR, Van der Starre P, et al. Lung transplant airway hypoxia: a diathesis to fibrosis? Am J Respir Crit Care Med. 2010;182(2):230–6.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Nicolls MR, Dhillon GS, Daddi N. A critical role for airway microvessels in lung transplantation. Am J Respir Crit Care Med. 2016;193(5):479–81.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Ahmad S, Shlobin OA, Nathan SD. Pulmonary complications of lung transplantation. Chest. 2011;139(2):402–11.PubMedCrossRefGoogle Scholar
  8. 8.
    Snell GI, Yusen RD, Weill D, Strueber M, Garrity E, Reed A, et al. Report of the ISHLT working group on primary lung graft dysfunction, part I: definition and grading-a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017;36(10):1097–103.PubMedCrossRefGoogle Scholar
  9. 9.
    Gelman AE, Fisher AJ, Huang HJ, Baz MA, Shaver CM, Egan TM, et al. Report of the ISHLT working group on primary lung graft dysfunction part III: mechanisms: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017;36(10):1114–20.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Diamond JM, Arcasoy S, Kennedy CC, Eberlein M, Singer JP, Patterson GM, et al. Report of the International Society for Heart and Lung Transplantation working group on primary lung graft dysfunction, part II: epidemiology, risk factors, and outcomes-a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017;36(10):1104–13.PubMedCrossRefGoogle Scholar
  11. 11.
    Van Raemdonck D, Hartwig MG, Hertz MI, Davis RD, Cypel M, Hayes D Jr, et al. Report of the ISHLT working group on primary lung graft dysfunction part IV: prevention and treatment: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017;36(10):1121–36.PubMedCrossRefGoogle Scholar
  12. 12.
    Evans CF, Iacono AT, Sanchez PG, Goloubeva O, Kim J, Timofte I, et al. Venous thromboembolic complications of lung transplantation: a contemporary single-institution review. Ann Thorac Surg. 2015;100(6):2033–9; discussion 9–40.PubMedCrossRefGoogle Scholar
  13. 13.
    Noda S, Sundt TM 3rd, Lynch JP, Trulock EP, Sundaresan S, Patterson GA. Pulmonary embolectomy after single-lung transplantation. Ann Thorac Surg. 1997;64(5):1459–61.PubMedCrossRefGoogle Scholar
  14. 14.
    Maziak DE, Maurer JR, Kesten S. Diaphragmatic paralysis: a complication of lung transplantation. Ann Thorac Surg. 1996;61(1):170–3.PubMedCrossRefGoogle Scholar
  15. 15.
    Ferdinande P, Bruyninckx F, Van Raemdonck D, Daenen W, Verleden G. Leuven lung transplant G. Phrenic nerve dysfunction after heart-lung and lung transplantation. J Heart Lung Transplant. 2004;23(1):105–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Shafi MA, Pasricha PJ. Post-surgical and obstructive gastroparesis. Curr Gastroenterol Rep. 2007;9(4):280–5.PubMedCrossRefGoogle Scholar
  17. 17.
    Hooft N, Smith M, Huang J, Bremner R, Walia R. Gastroparesis is common after lung transplantation and may be ameliorated by botulinum toxin-a injection of the pylorus. J Heart Lung Transplant. 2014;33(12):1314–6.PubMedCrossRefGoogle Scholar
  18. 18.
    Au J, Hawkins T, Venables C, Morritt G, Scott CD, Gascoigne AD, et al. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg. 1993;55(1):94–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Ferrer J, Roldan J, Roman A, Bravo C, Monforte V, Pallissa E, et al. Acute and chronic pleural complications in lung transplantation. J Heart Lung Transplant. 2003;22(11):1217–25.PubMedCrossRefGoogle Scholar
  20. 20.
    Arndt A, Boffa DJ. Pleural space complications associated with lung transplantation. Thorac Surg Clin. 2015;25(1):87–95.PubMedCrossRefGoogle Scholar
  21. 21.
    Judson MA, Handy JR, Sahn SA. Pleural effusion from acute lung rejection. Chest. 1997;111(4):1128–30.PubMedCrossRefGoogle Scholar
  22. 22.
    Chhajed PN, Bubendorf L, Hirsch H, Boehler A, Weder W, Tamm M. Mesothelioma after lung transplantation. Thorax. 2006;61(10):916–7.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Paranjpe DV, Wittich GR, Hamid LW, Bergin CJ. Frequency and management of pneumothoraces in heart-lung transplant recipients. Radiology. 1994;190(1):255–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Engeler CE, Olson PN, Engeler CM, Carpenter BL, Crowe JE, Day DL, et al. Shifting pneumothorax after heart-lung transplantation. Radiology. 1992;185(3):715–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Anaya-Ayala JE, Loebe M, Davies MG. Endovascular management of early lung transplant-related anastomotic pulmonary artery stenosis. J Vasc Interv Radiol. 2015;26(6):878–82.PubMedCrossRefGoogle Scholar
  26. 26.
    Schulman LL, Anandarangam T, Leibowitz DW, Ditullio MR, McGregor CC, Galantowicz ME, et al. Four-year prospective study of pulmonary venous thrombosis after lung transplantation. J Am Soc Echocardiogr. 2001;14(8):806–12.PubMedCrossRefGoogle Scholar
  27. 27.
    Gonzalez-Fernandez C, Gonzalez-Castro A, Rodriguez-Borregan JC, Lopez-Sanchez M, Suberviola B, Francisco Nistal J, et al. Pulmonary venous obstruction after lung transplantation. Diagnostic advantages of transesophageal echocardiography. Clin Transpl. 2009;23(6):975–80.CrossRefGoogle Scholar
  28. 28.
    Meyers BF, de la Morena M, Sweet SC, Trulock EP, Guthrie TJ, Mendeloff EN, et al. Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg. 2005;129(6):1421–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Santacruz JF, Mehta AC. Airway complications and management after lung transplantation: ischemia, dehiscence, and stenosis. Proc Am Thorac Soc. 2009;6(1):79–93.PubMedCrossRefGoogle Scholar
  30. 30.
    Herrera JM, McNeil KD, Higgins RS, Coulden RA, Flower CD, Nashef SA, et al. Airway complications after lung transplantation: treatment and long-term outcome. Ann Thorac Surg. 2001;71(3):989–93; discussion 93–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Hasegawa T, Iacono AT, Orons PD, Yousem SA. Segmental nonanastomotic bronchial stenosis after lung transplantation. Ann Thorac Surg. 2000;69(4):1020–4.PubMedCrossRefGoogle Scholar
  32. 32.
    McManigle W, Pavlisko EN, Martinu T. Acute cellular and antibody-mediated allograft rejection. Semin Respir Crit Care Med. 2013;34(3):320–35.PubMedCrossRefGoogle Scholar
  33. 33.
    De Vito DA, Hoffman LA, Iacono AT, Zullo TG, McCurry KR, Dauber JH. Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation? Heart Lung. 2004;33(6):372–80.CrossRefGoogle Scholar
  34. 34.
    Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest. 1992;102(4):1049–54.PubMedCrossRefGoogle Scholar
  35. 35.
    Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26(12):1229–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Martinu T, Pavlisko EN, Chen DF, Palmer SM. Acute allograft rejection: cellular and humoral processes. Clin Chest Med. 2011;32(2):295–310.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Levine SM. Transplant/immunology network of the American College of Chest P. A survey of clinical practice of lung transplantation in North America. Chest. 2004;125(4):1224–38.PubMedCrossRefGoogle Scholar
  38. 38.
    Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, et al. Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2016;35(4):397–406.PubMedCrossRefGoogle Scholar
  39. 39.
    Witt CA, Gaut JP, Yusen RD, Byers DE, Iuppa JA, Bennett Bain K, et al. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2013;32(10):1034–40.PubMedCrossRefGoogle Scholar
  40. 40.
    Morrell MR, Patterson GA, Trulock EP, Hachem RR. Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant. 2009;28(1):96–100.PubMedCrossRefGoogle Scholar
  41. 41.
    Verleden SE, Vos R, Vanaudenaerde BM, Verleden GM. Chronic lung allograft dysfunction phenotypes and treatment. J Thorac Dis. 2017;9(8):2650–9.PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Gauthier JM, Hachem RR, Kreisel D. Update on chronic lung allograft dysfunction. Curr Transplant Rep. 2016;3(3):185–91.PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Weigt SS, DerHovanessian A, Wallace WD, Lynch JP 3rd, Belperio JA. Bronchiolitis obliterans syndrome: the Achilles’ heel of lung transplantation. Semin Respir Crit Care Med. 2013;34(3):336–51.PubMedPubMedCentralCrossRefGoogle Scholar
  44. 44.
    Meyer KC, Raghu G, Verleden GM, Corris PA, Aurora P, Wilson KC, et al. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J. 2014;44(6):1479–503.PubMedCrossRefGoogle Scholar
  45. 45.
    Benden C, Haughton M, Leonard S, Huber LC. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: a systematic review. J Heart Lung Transplant. 2017;36(9):921–33.PubMedCrossRefGoogle Scholar
  46. 46.
    Verleden SE, Vandermeulen E, Ruttens D, Vos R, Vaneylen A, Dupont LJ, et al. Neutrophilic reversible allograft dysfunction (NRAD) and restrictive allograft syndrome (RAS). Semin Respir Crit Care Med. 2013;34(3):352–60.PubMedCrossRefGoogle Scholar
  47. 47.
    Sato M, Waddell TK, Wagnetz U, Roberts HC, Hwang DM, Haroon A, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30(7):735–42.PubMedCrossRefGoogle Scholar
  48. 48.
    Collett D, Mumford L, Banner NR, Neuberger J, Watson C. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant. 2010;10(8):1889–96.PubMedCrossRefGoogle Scholar
  49. 49.
    Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306(17):1891–901.PubMedPubMedCentralCrossRefGoogle Scholar
  50. 50.
    Arcasoy SM, Hersh C, Christie JD, Zisman D, Pochettino A, Rosengard BR, et al. Bronchogenic carcinoma complicating lung transplantation. J Heart Lung Transplant. 2001;20(10):1044–53.PubMedCrossRefGoogle Scholar
  51. 51.
    Bharat A, Cunningham SA, Scott Budinger GR, Kreisel D, DeWet CJ, Gelman AE, et al. Disseminated ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med. 2015;7(284):284re3.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Ye X, Kuo HT, Sampaio MS, Jiang Y, Bunnapradist S. Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients. Clin Transpl. 2011;25(6):885–91.CrossRefGoogle Scholar
  53. 53.
    Hackman KL, Snell GI, Bach LA. Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study. Diabetes Care. 2014;37(11):2919–25.PubMedCrossRefGoogle Scholar
  54. 54.
    Wehbe E, Brock R, Budev M, Xu M, Demirjian S, Schreiber MJ Jr, et al. Short-term and long-term outcomes of acute kidney injury after lung transplantation. J Heart Lung Transplant. 2012;31(3):244–51.PubMedCrossRefGoogle Scholar
  55. 55.
    Fidalgo P, Ahmed M, Meyer SR, Lien D, Weinkauf J, Cardoso FS, et al. Incidence and outcomes of acute kidney injury following orthotopic lung transplantation: a population-based cohort study. Nephrol Dial Transplant. 2014;29(9):1702–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Paradela de la Morena M, De La Torre BM, Prado RF, Roel MD, Salcedo JA, Costa EF, et al. Chronic kidney disease after lung transplantation: incidence, risk factors, and treatment. Transplant Proc. 2010;42(8):3217–9.Google Scholar
  57. 57.
    Yu TM, Lin CL, Chang SN, Sung FC, Huang ST, Kao CH. Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study. Mayo Clin Proc. 2014;89(7):888–95.PubMedCrossRefGoogle Scholar
  58. 58.
    Shane E, Papadopoulos A, Staron RB, Addesso V, Donovan D, McGregor C, et al. Bone loss and fracture after lung transplantation. Transplantation. 1999;68(2):220–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Raghavan D, Gao A, Ahn C, Torres F, Mohanka M, Bollineni S, et al. Contemporary analysis of incidence of post-operative atrial fibrillation, its predictors, and association with clinical outcomes in lung transplantation. J Heart Lung Transplant. 2015;34(4):563–70.PubMedCrossRefGoogle Scholar
  60. 60.
    Orrego CM, Cordero-Reyes AM, Estep JD, Seethamraju H, Scheinin S, Loebe M, et al. Atrial arrhythmias after lung transplant: underlying mechanisms, risk factors, and prognosis. J Heart Lung Transplant. 2014;33(7):734–40.PubMedCrossRefGoogle Scholar
  61. 61.
    Silverborn M, Jeppsson A, Martensson G, Nilsson F. New-onset cardiovascular risk factors in lung transplant recipients. J Heart Lung Transplant. 2005;24(10):1536–43.PubMedCrossRefGoogle Scholar
  62. 62.
    Maury G, Langer D, Verleden G, Dupont L, Gosselink R, Decramer M, et al. Skeletal muscle force and functional exercise tolerance before and after lung transplantation: a cohort study. Am J Transplant. 2008;8(6):1275–81.PubMedCrossRefGoogle Scholar
  63. 63.
    Lands LC, Smountas AA, Mesiano G, Brosseau L, Shennib H, Charbonneau M, et al. Maximal exercise capacity and peripheral skeletal muscle function following lung transplantation. J Heart Lung Transplant. 1999;18(2):113–20.PubMedCrossRefGoogle Scholar
  64. 64.
    Aguilar-Guisado M, Givalda J, Ussetti P, Ramos A, Morales P, Blanes M, et al. Pneumonia after lung transplantation in the RESITRA cohort: a multicenter prospective study. Am J Transplant. 2007;7(8):1989–96.PubMedCrossRefGoogle Scholar
  65. 65.
    Clark NM, Reid GE, Practice ASTIDCo. Nocardia infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):83–92.PubMedCrossRefGoogle Scholar
  66. 66.
    Palmer SM, Alexander BD, Sanders LL, Edwards LJ, Reller LB, Davis RD, et al. Significance of blood stream infection after lung transplantation: analysis in 176 consecutive patients. Transplantation. 2000;69(11):2360–6.PubMedCrossRefGoogle Scholar
  67. 67.
    Nunley DR, Grgurich WF, Keenan RJ, Dauber JH. Empyema complicating successful lung transplantation. Chest. 1999;115(5):1312–5.PubMedCrossRefGoogle Scholar
  68. 68.
    van Duin D, van Delden C, Practice ASTIDCo. Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):31–41.PubMedCrossRefGoogle Scholar
  69. 69.
    Dobbin C, Maley M, Harkness J, Benn R, Malouf M, Glanville A, et al. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral Centre. J Hosp Infect. 2004;56(4):277–82.PubMedCrossRefGoogle Scholar
  70. 70.
    Garzoni C, Vergidis P, Practice ASTIDCo. Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):50–8.PubMedCrossRefGoogle Scholar
  71. 71.
    de Bruyn G, Whelan TP, Mulligan MS, Raghu G, Limaye AP. Invasive pneumococcal infections in adult lung transplant recipients. Am J Transplant. 2004;4(8):1366–71.PubMedCrossRefGoogle Scholar
  72. 72.
    Dubberke ER, Riddle DJ, Practice ASTIDCo. Clostridium difficile in solid organ transplant recipients. Am J Transplant. 2009;9(Suppl 4):S35–40.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Bhaskaran A, Hosseini-Moghaddam SM, Rotstein C, Husain S. Mold infections in lung transplant recipients. Semin Respir Crit Care Med. 2013;34(3):371–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Silveira FP, Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med. 2008;14(3):211–8.PubMedCrossRefGoogle Scholar
  75. 75.
    Miller R, Assi M, Practice ASTIDCo. Endemic fungal infections in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):250–61.PubMedCrossRefGoogle Scholar
  76. 76.
    Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis. 2001;7(3):375–81.PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Clark NM, Lynch JP 3rd, Sayah D, Belperio JA, Fishbein MC, Weigt SS. DNA viral infections complicating lung transplantation. Semin Respir Crit Care Med. 2013;34(3):380–404.PubMedCrossRefGoogle Scholar
  78. 78.
    Zamora MR. Cytomegalovirus and lung transplantation. Am J Transplant. 2004;4(8):1219–26.PubMedCrossRefGoogle Scholar
  79. 79.
    Gottlieb J, Schulz TF, Welte T, Fuehner T, Dierich M, Simon AR, et al. Community-acquired respiratory viral infections in lung transplant recipients: a single season cohort study. Transplantation. 2009;87(10):1530–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Singer JP, Singer LG. Quality of life in lung transplantation. Semin Respir Crit Care Med. 2013;34(3):421–30.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care, Department of MedicineStanford University School of MedicineStanfordUSA

Personalised recommendations